Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Christian Reinhardt

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Annals of Clinical and Translational Neurology|April 30, 2022
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
Journal of Neurology|April 4, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
International Journal of Molecular Sciences|September 10, 2021
Altered DNA Methylation Profiles in <i>SF3B1</i> Mutated CLL PatientsAlicja Pacholewska, Christina Grimm, Carmen D Herling, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
Cancers|July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse ModelMaximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Investigational New Drugs|November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancerJohanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
Cancers|April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaStephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Frontiers in Oncology|October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspectiveAnn-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Annals of Clinical and Translational Neurology|April 30, 2022
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
Journal of Neurology|April 4, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
International Journal of Molecular Sciences|September 10, 2021
Altered DNA Methylation Profiles in <i>SF3B1</i> Mutated CLL PatientsAlicja Pacholewska, Christina Grimm, Carmen D Herling, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
Cancers|July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse ModelMaximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Investigational New Drugs|November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancerJohanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
Cancers|April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaStephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Frontiers in Oncology|October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspectiveAnn-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Pageof 12